A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: The DREAM to TREAT AD study protocol - Gribaleva,E.; Krogh,N.S.; Prieto-Merino,D.; Coker,B.; Jackson,A.; Akkoc,A.; Birkner,T.; Bruninx,E.; Hennessy,C.; Chan,K.; Cutlar,L.; Farrell,B.; et al. (Skin Health and Disease, 2025)